Skip to content

Sichenzia Ross Friedman Ference LLP Advises Rightscorp Inc. on Reverse Merger and $1.0M Financing

Synergy Pharmaceuticals, Inc.

Northwest Biotherapeutics, Inc.

Bitcoin Shop, Inc.

Sichenzia Ross Friedman Ference LLP Advises Synergy Pharmaceuticals, Inc. on $90 Million Public Offering

Sichenzia Ross Friedman Ference LLP Advises Synergy Pharmaceuticals, Inc. on $103 Million Public Offering.

DelMar Pharmaceuticals, Inc.

Oculus Innovative Sciences, Inc.

Sichenzia Ross Friedman Ference LLP To Sponsor the 25th Annual Roth OC Conference from March 17th – 20th in Dana Point, CA

Sichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals, Inc. on $10.5M Reverse Merger and Financing

Sports Teams Are Selling The Jerseys Off Their Players’ Backs But Are They Violating The Law In The Process?

5 Reasons Why Equity-Based Crowdfunding Under the JOBS Act Won’t Work

5 Reasons Why Equity-Based Crowdfunding Under the JOBS Act Won’t Work

Towerstream Corporation

Northwest Biotherapeutics, Inc.

Jeffrey Fessler Attends the NASDAQ Opening Bell Ringing with Northwest Biotherapeutics, Inc. (NWBO)

Jeffrey Fessler Attends the NASDAQ Opening Bell Ringing with Northwest Biotherapeutics, Inc. (NWBO)

SICHENZIA ROSS FRIEDMAN FERENCE LLP Welcomes Bankruptcy Partner Ralph E. Preite

Hurricane Sandy Update

Hurricane Sandy Update

Pure Biosciences, Inc.